pocketful logo light
pocketful logo light
Windlas Biotech Ltd logo

Windlas Biotech Ltd

NSE: WINDLAS BSE: 543329

₹871.55

(3.23%)

Wed, 22 Jul 2026, 08:03 pm

mtf coin illustrationMTF 5x

Windlas Biotech Share Price Live Chart

1 Day

(3.23%)

No Result Found

Summary

  • Market Cap (in Cr)

    1717.35

  • Net Profit (in Cr)

    60.99

  • P/B

    4.31

  • Sector P/E

    33.76

  • P/E

    35.78

  • EV/EBITDA

    19.61

  • Debt/Equity (Industry)

    0.26

  • Interest Cover (Industry)

    10.81

  • ROCE (Industry)

    16.40

  • RONW (Industry)

    14.39

  • ROE

    12.76

  • ROCE

    16.87

  • Debt/Equity

    0.04

  • EPS (TTM)

    32.20

  • Dividend Yield

    0.77

  • Book Value

    281.35

  • Interest Cover

    19.21

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters61.9061.9961.9962.3462.34
FII0.600.931.111.441.52
DII11.8111.4411.4311.2110.89
Public25.7025.6425.4725.0125.25
Government00000

Read More

Technical Analysis

RSI

58.33

MACD

8.87

50 DMA

826.10

200 DMA

821.57

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic1054.13951.83905.57849.53803.27747.23644.93
Fibonacci951.83912.75888.61849.53810.45786.31747.23
Camarilla887.43878.05868.68849.53849.92840.54831.17

Pivots Level: Classic

R3

+204.60

1054.13

R2

+102.30

951.83

R1

+56.03

905.57

849.53
849.53
Pivot Point
LTP: 869.90

S1

-46.27

803.27

S2

-102.30

747.23

S3

-204.60

644.93

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    858.32

  • 20-EMA

    851.24

  • 30-EMA

    845.61

  • 50-EMA

    836.77

  • 100-EMA

    827.35

  • 200-EMA

    835.24

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
21 May 2026board-meetingsAccounts, Quarterly Results, Final Dividend
17 Apr 2026buyback
05 Feb 2026board-meetingsQuarterly Results
06 Nov 2025board-meetingsQuarterly Results, Half Yearly Results
04 Jul 2025agm
21 Jun 2025dividendFinal Dividend - Rs. - 5.821 Jul 2025
22 May 2025dividend₹5.80 Dividend /Share21 Jul 2025
02 Sept 2024agm
17 Aug 2024agmAnnual General Meeting18 Sept 2024
17 Aug 2024dividendDividend - Rs 5.50 Per Share17 Sept 2024

Read More

Peer Comparison

Windlas Biotech Ltd logo

Windlas Biotech Ltd

Cipla Ltd logo

Cipla Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Read More

Windlas Biotech Ltd About

Windlas Biotech is engaged in manufacturing and trading of pharmaceutical products.

Industry

Pharmaceuticals - Indian - Formulations

Founded

2001

Headquarters

CEO

Vivek Dhariwal

Employees

Contact

Website icon

Website

http://www.windlasbiotech.com

Email icon

Email

grievance@windlasbiotech.com

Phone icon

Phone

91-135-6608000

Location icon

Location

40/1 Mohabewala Industrial, Area, Dehradun, Uttarakhand, 248110

Read More

Windlas Biotech Ltd Company History

YearHistory
2016
  • The Company was converted into a private limited company.
  • A fresh certificate of incorporation consequent upon conversion and change of name to Windlas Biotech Private Limited was granted.
2017
  • Revenues crossed Rs. 3,000 million for the FY 2016-17.
2018
  • The Company launched its first product in the United States from Dehradun Plant – IV.
  • The Company commenced operations at Dehradun Plant – III.
2021
  • The Company was converted from a private limited company to a public limited company.
  • The name of the Company was changed to Windlas Biotech Limited.
  • A fresh certificate of incorporation was granted by the RoC.
  • Approval of Scheme of Amalgamation of the erstwhile subsidiary, Windlas Healthcare, with and into the Company was obtained.
2022
  • The Company received a certificate of Good Manufacturing Practices (GMP) from SAHPRA.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
AJAY KUMAR AGGARWALbulkBuy144995787.4220 Feb 2025
SAMVITTI CAPITAL PRIVATE LIMITED ACTIVE ALPHA MULTICAPbulkSell115374683.4919 Feb 2025
GRAVITON RESEARCH CAPITAL LLPbulkSell110668564.9401 Mar 2024
GRAVITON RESEARCH CAPITAL LLPbulkBuy110668565.9601 Mar 2024
GRAVITON RESEARCH CAPITAL LLPbulkSell135363522.2708 Feb 2024
GRAVITON RESEARCH CAPITAL LLPbulkBuy135363522.3908 Feb 2024
JAINAM BROKING LIMITEDbulkBuy150028511.502 Jan 2024
GRAVITON RESEARCH CAPITAL LLPbulkSell409737517.502 Jan 2024
GRAVITON RESEARCH CAPITAL LLPbulkBuy409737517.1702 Jan 2024
JAINAM BROKING LIMITEDbulkSell96128520.702 Jan 2024

Read More

Windlas Biotech Ltd News

Windlas Biotech to host analyst meet

Windlas Biotech will hold a virtual analyst meet on July 14, 2026. No unpublished price sensitive information will be shared.

09 Jul 2026

companies

Windlas Biotech fixes July 16 as dividend record date

Windlas Biotech has fixed July 16, 2026, as the record date to determine eligibility for dividend for FY26. The 25th AGM is scheduled for July 23 via video conferencing.

30 Jun 2026

companies

Windlas Biotech to meet investors on July 2

Windlas Biotech Limited will hold meetings with Vara Capital and Apricus Wealth Investment Managers on July 2, 2026. The sessions will be conducted in-person and will not involve sharing unpublished price sensitive information.

24 Jun 2026

companies

Windlas Biotech uploads Q4FY26 call recording

Windlas Biotech has uploaded the audio recording of its Q4FY26 conference call. The recording covers audited consolidated and standalone results for FY26.

22 May 2026

companies

Windlas Biotech grants 37,000 stock options

Windlas Biotech granted 37,000 stock options under ESOS 2023 and Windlas Plan 2025. Options vest over 1-4 years.

21 May 2026

companies

Read More

Open Your Free Demat Account

Enter your phone number